Triangle Capital Corporation  

(Public, NYSE:TCAP)   Watch this stock  
Find more results for TCAP
24.64
-0.17 (-0.69%)
Real-time:   2:57PM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 24.59 - 24.95
52 week 18.18 - 28.67
Open 24.82
Vol / Avg. 151,434.00/196,934.00
Mkt cap 814.85M
P/E 23.66
Div/yield 0.54/8.77
EPS 1.04
Shares 33.19M
Beta 0.63
Inst. own 24%
May 7, 2015
Q1 2015 Triangle Capital Corp Earnings Call Add to calendar
May 6, 2015
Q1 2015 Triangle Capital Corp Earnings Release - 4:00PM EDT - Add to calendar
May 6, 2015
Triangle Capital Corp Annual Shareholders Meeting - 8:30AM EDT - Add to calendar
Mar 2, 2015
Q4 2014 Triangle Capital Corp Earnings Release
Mar 2, 2015
Q4 2014 Triangle Capital Corp Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 1.56% 27.14%
Operating margin 59.03% 59.34%
EBITD margin - 59.39%
Return on average assets 0.20% 3.15%
Return on average equity 0.36% 5.81%
Employees 25 -
CDP Score - -

Address

3700 Glenwood Ave Ste 530
RALEIGH, NC 27612-5539
United States - Map
+1-919-7194770 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Triangle Capital Corporation is a specialty finance company that provides customized financing solutions to lower middle market companies located throughout the United States. The Company operates as a non-diversified investment company. Its business is to provide capital to lower middle market companies in the United States. Its investment objective is to seek returns by generating current income from its debt investments and capital appreciation from its equity related investments. It invests primarily in subordinated debt securities secured by second lien security interests in portfolio company assets. On a more limited basis, it also invests in senior debt securities secured by first lien security interests in portfolio companies. Effective January 23, 2014, Triangle Capital Corp acquired an undisclosed minority stake in Danville Materials Inc, a manufacturer and wholesaler of dental equipment and supplies.

Officers and directors

Garland S. Tucker III Chairman of the Board, Chief Executive Officer
Age: 66
Bio & Compensation  - Reuters
E. Ashton Poole President, Chief Operating Officer, Director
Age: 47
Bio & Compensation  - Reuters
Steven C. Lilly Chief Financial Officer, Chief Compliance Officer, Treasurer, Secretary, Director
Age: 44
Bio & Compensation  - Reuters
Brent P. W. Burgess Chief Investment Officer, Director
Age: 47
Bio & Compensation  - Reuters
W. McComb Dunwoody Independent Director
Bio & Compensation  - Reuters
Mark M. Gambill Independent Director
Age: 63
Bio & Compensation  - Reuters
Benjamin S. Goldstein Independent Director
Age: 58
Bio & Compensation  - Reuters
Simon B. Rich Jr. Independent Director
Age: 69
Bio & Compensation  - Reuters
Sherwood H. Smith Jr. Independent Director
Age: 79
Bio & Compensation  - Reuters